This study examined how loss of GLP-1 coverage affected employee perceptions of their employer and workforce stability.<h4>Methods</h4>This study analyzed data from employees of a healthcare system that discontinued GLP-1 obesity medication coverage. The gene discussed is GLP1R; the disease is obesity due to melanocortin 4 receptor deficiency.